US Patent Issued to Alnylam Pharmaceuticals, Vir Biotechnology on Aug. 19 for "Coronavirus IRNA compositions and methods of use thereof" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,945, issued on Aug. 19, was assigned to Alnylam Pharmaceuticals Inc. (Cambridge, Mass.) and Vir Biotechnology Inc. (San Francisco).

"Coronavirus IRNA compositions and methods of use thereof" was invented by Akin Akinc (Needham, Mass.), James D. McIninch (Burlington, Mass.), Yesseinia Anglero-Rodriguez (Cambridge, Mass.), Mark K. Schlegel (Boston), Christy M. Hebner (San Francisco) and Florian A. Lempp (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to RNAi agents, e.g., dsRNA agents, targeting the coronavirus genome. The invention also relates to methods of using such RNAi agents to inhibit expression of a...